Lineage Cell Therapeutics Inc (LCTX) (Q3 2026) Earnings Call Highlights: NeuroAermid ...
Lineage Cell Therapeutics Inc (LCTX) bolsters its pipeline with the clinical-stage HUNT-1 neural stem cell program for Huntington's disease while reporting $45.2 million in cash and progress across Related Stocks: LCTX ,